An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.
about
Molecular basis of host specificity in human pathogenic bacteriaProperdin: a tightly regulated critical inflammatory modulatorInfections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyCombination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritisComplement control protein factor H: the good, the bad, and the inadequate.Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complementMeningococcal disease and the complement system.Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycansA scabies mite serpin interferes with complement-mediated neutrophil functions and promotes staphylococcal growth.Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding protein.Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidisProperdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein.Quantitative Modeling of the Alternative Pathway of the Complement SystemComplement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes - An in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions.Complement activation, regulation, and molecular basis for complement-related diseasesLoss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency.Local release of properdin in the cellular microenvironment: role in pattern recognition and amplification of the alternative pathway of complement.Properdin-Mediated C5a Production Enhances Stable Binding of Platelets to Granulocytes in Human Whole Blood.Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).OPSI threat in hematological patients.Properdin binding to complement activating surfaces depends on initial C3b deposition.Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection.Native properdin binds to Chlamydia pneumoniae and promotes complement activationCrosstalk between complement and toll-like receptors.Properdin in complement activation and tissue injury.Parasitic scabies mites and associated bacteria joining forces against host complement defence.Structural insight into proteolytic activation and regulation of the complement system.Complement's hidden arsenal: New insights and novel functions inside the cell.Properdin and factor h: opposing players on the alternative complement pathway "see-saw".The High Prevalence of Functional Complement Defects Induced by Chemotherapy.Functional and structural insight into properdin control of complement alternative pathway amplification.Interferon α-Enhanced Clearance of Group A Streptococcus Despite Neutropenia.Anticoagulants impact on innate immune responses and bacterial survival in whole blood models of Neisseria meningitidis infection.
P2860
Q26864388-59898D7D-6BFC-47E6-B954-EF6B714DD948Q28069187-EFE8FD4A-6C47-4D14-8384-EAB7A10D0823Q28972389-35CA8983-A5CD-4E2E-BDF3-DF2CF5768828Q30415634-B519A388-C9FB-4CE6-BCE4-312E42052763Q34067107-10EEDB81-2943-41FB-9A8D-C09BAAB2BD41Q34172424-FA256690-820D-418F-9EDA-9FA9E567E760Q34376170-A374DD55-59F6-4177-91CE-6EECEB498116Q35187024-0DD4118A-ED7A-4BB0-8FB8-D9DF68AFE35AQ35191212-2B7C4C79-0700-4643-A6F8-8E944913F8F2Q35665404-166EC3AC-C8DA-441D-BE87-946A481D174AQ35689526-91E0E2FB-8A21-4954-ADA1-62DC6AD458ADQ35850975-7223D2F7-430D-405A-AA96-D16D890B9922Q35975481-61B88B67-B3CD-4DA6-B966-91031C7D5FAEQ36302638-81073F2A-E2C7-4912-9C33-273EF690A37FQ36380682-7A78709E-42D0-4121-B2E2-913DEF26C0ECQ36509318-5A421E9E-9158-41E7-8EBE-F5B3E2D8A5F9Q36540594-3EEE7CCA-5391-4CF4-9EF7-357506E1175EQ36955789-19AEEF96-CDDB-4929-8D6A-514EA0E73046Q37200463-6B937BA8-4DF0-4901-A935-298A3CE0692FQ37313366-8BDE1CB2-3CA6-4029-8D44-96D90513E24CQ37612601-6FE98BDE-C0EF-468A-AC8E-ABF508A2B5A1Q37701996-5FA08160-8380-4340-B3D6-4C981330B806Q37851796-5D7C394E-3B05-4C93-88B4-784D85DAD199Q37959890-F07B5646-0AEA-4C78-A8D1-F3B7BF353F45Q38118454-4EE9C4F3-E0B8-4486-920C-AB5B81309CC0Q38235740-A08F7D9C-74C4-442A-90E3-307AAD0832B5Q38991069-33756AD6-9111-49E8-85FF-64DFAFCD86A3Q39135367-FA24CB0C-82EA-4307-B8EE-EA7B12B7C312Q39158331-C823E062-3164-4EC5-AC11-5515F4D86C29Q39229243-0D0FE9A7-26CB-41B3-B496-A08697D32E7CQ40306147-4793D659-AE4E-4509-9E14-44CBD4B6B049Q40638602-810C198A-DAF5-4062-86CE-B766AD5F134EQ55608033-BFE6F330-59ED-429D-A5B0-554F78FF6B85
P2860
An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
An evaluation of the role of p ...... dis and Neisseria gonorrhoeae.
@ast
An evaluation of the role of p ...... dis and Neisseria gonorrhoeae.
@en
An evaluation of the role of p ...... dis and Neisseria gonorrhoeae.
@nl
type
label
An evaluation of the role of p ...... dis and Neisseria gonorrhoeae.
@ast
An evaluation of the role of p ...... dis and Neisseria gonorrhoeae.
@en
An evaluation of the role of p ...... dis and Neisseria gonorrhoeae.
@nl
prefLabel
An evaluation of the role of p ...... dis and Neisseria gonorrhoeae.
@ast
An evaluation of the role of p ...... dis and Neisseria gonorrhoeae.
@en
An evaluation of the role of p ...... dis and Neisseria gonorrhoeae.
@nl
P2093
P2860
P356
P1476
An evaluation of the role of p ...... dis and Neisseria gonorrhoeae.
@en
P2093
Claudio Cortes
Michael K Pangburn
Peter A Rice
Sanjay Ram
Sarika Agarwal
Viviana P Ferreira
P2860
P304
P356
10.4049/JIMMUNOL.0903598
P407
P577
2010-06-07T00:00:00Z